These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1255496)

  • 41. Stereospecific antibodies to methadone. II. Synthesis of d- and 1-methadone antigens.
    Bartos F; Bartos D; Olsen GD; Anderson B; Daves GD
    Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):157-64. PubMed ID: 566457
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Brain distribution of propranolol in the rat.
    Elghozi JL; Bianchetti G; Morselli PL; Meyer P
    Eur J Pharmacol; 1979 May; 55(3):319-22. PubMed ID: 456429
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Towards artificial antibodies prepared by molecular imprinting.
    Ansell RJ; Ramström O; Mosbach K
    Clin Chem; 1996 Sep; 42(9):1506-12. PubMed ID: 8787721
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calcium binding properties of rat heart plasma membrane and inhibition by structural analogues of dl-propranolol.
    Feldman DA; Weinhold PA
    Biochem Pharmacol; 1977 Dec; 26(23):2283-9. PubMed ID: 588310
    [No Abstract]   [Full Text] [Related]  

  • 45. Radioimmunoassay of cyclazocine and stereospecificity of antibody.
    Maeda M; Tsuji A
    J Pharmacobiodyn; 1981 Mar; 4(3):167-74. PubMed ID: 7252767
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacological and metabolic studies with propranolol in man.
    Conolly ME; Paterson JW; Dollery CT; Hayes A; Cooper RG
    Clin Sci; 1970 Feb; 38(2):10P. PubMed ID: 5416143
    [No Abstract]   [Full Text] [Related]  

  • 47. In vitro interaction between aspirin & propranolol at the plasma protein binding sites.
    Tekur U; Bindal M; Sen P; Mahajan P
    Indian J Med Res; 1987 Jul; 86():95-100. PubMed ID: 3692567
    [No Abstract]   [Full Text] [Related]  

  • 48. Simultaneous determination of the propranolol enantiomers in biological samples by gas--liquid chromatography.
    Caccia S; Guiso G; Ballabio M; De Ponte P
    J Chromatogr; 1979 Apr; 172():457-62. PubMed ID: 548541
    [No Abstract]   [Full Text] [Related]  

  • 49. Radioimmunoassay of propranolol.
    Eller TD; Knapp DR; Walle T
    Anal Chem; 1983 Aug; 55(9):1572-5. PubMed ID: 6638523
    [No Abstract]   [Full Text] [Related]  

  • 50. Stereoselectivity of antibodies for the bioanalysis of chiral drugs.
    Got PA; Scherrmann JM
    Pharm Res; 1997 Nov; 14(11):1516-23. PubMed ID: 9434269
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma levels of (+) and (-)-propranolol and 4-hydroxypropranolol after administration of racemic (+/-)-propranolol in man.
    Von Bahr C; Hermansson J; Tawara K
    Br J Clin Pharmacol; 1982 Jul; 14(1):79-82. PubMed ID: 7104170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A standard approach to compiling clinical pharmacokinetic data.
    Sheiner LB; Benet LZ; Pagliaro LA
    J Pharmacokinet Biopharm; 1981 Feb; 9(1):59-127. PubMed ID: 7014827
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics and pharmacodynamics of propranolol stereoisomers in hyperthyroid patients.
    Tawara K; Kawashima K; Ishikawa H; Yamamoto K; Saito K; Ebihara A; Yoshida S
    Eur J Clin Pharmacol; 1981 Feb; 19(3):197-203. PubMed ID: 6894282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics of l-propranolol during repetitive dosing in normal and uranyl nitrate-induced renal failure rats.
    Terao N; Shen DD
    J Pharmacokinet Biopharm; 1984 Oct; 12(5):479-93. PubMed ID: 6520744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of radioreceptor assay and radioimmunoassay for atropine: pharmacokinetic application.
    Aaltonen L; Kanto J; Iisalo E; Pihlajamäki K
    Eur J Clin Pharmacol; 1984; 26(5):613-7. PubMed ID: 6468478
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical pharmacology of a new beta-adrenoceptor blocking drug, befunolol. Cross-over comparison with propranolol on repeated administration.
    Ebihara A; Tawara K; Oka T; Ofuji T; Kawahara K
    Eur J Clin Pharmacol; 1982; 23(3):189-95. PubMed ID: 6129139
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of a radioreceptor assay for beta-adrenoceptor antagonists in plasma.
    Barnett DB; Batta M; Davies B; Nahorski SR
    Eur J Clin Pharmacol; 1980 May; 17(5):349-54. PubMed ID: 6106550
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Importance of drug enantiomers in clinical pharmacology.
    Williams K; Lee E
    Drugs; 1985 Oct; 30(4):333-54. PubMed ID: 3905334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The assessment of the beta-blocking activity of urapidil: a new method.
    Jamieson MJ; Jackson SH; Patel SS; Shepherd AM; Galbraith H; Stewart W; Flanagan PH
    Eur J Clin Pharmacol; 1986; 31(2):149-54. PubMed ID: 2879734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circadian influence on effect of propranolol on exercise-induced tachycardia in healthy subjects.
    Fujimura A; Kumagai Y; Sugimoto K; Nakashima H; Kajiyama H; Ebihara A; Ohashi K
    Eur J Clin Pharmacol; 1990; 38(2):133-7. PubMed ID: 2338109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.